Hypercalcemia of Malignancy
📧 Sign up to get email alerts when something new happens for Hypercalcemia of Malignancy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-21FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for zoledronic acid from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2015-05-27FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approved a supplemental application for zoledronic acid from BPI Labs LLC under an ANDA.
-
FDA approval · 2015-04-09FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Dr.Reddy's Laboratories Ltd)
FDA approved a supplemental application for zoledronic acid from Dr. Reddy's Laboratories Ltd (ANDA 091363), granting regulatory approval of…
-
FDA approval · 2013-09-23FDA Approved: ZOLEDRONIC ACID — Original Application (Sagent Pharmaceuticals)
FDA approves a generic zoledronic acid injection from Sagent Pharmaceuticals under ANDA 202828, granting approval to market the product for …
-
FDA approval · 2013-06-03FDA Approved: ZOLEDRONIC ACID — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic zoledronic acid injectable product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-03-29FDA Approved: ZOLEDRONIC ACID — Original Application (Dr.Reddy's Laboratories Ltd)
FDA approved the original application for Zoledronic acid (generic) from Dr. Reddy's Laboratories Ltd. This approval confirms a generic vers…
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Mylan Institutional LLC)
FDA approved an original application for a zoledronic acid generic product manufactured by Mylan Institutional LLC.
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's zoledronic acid under an original application, enabling a generic version of the drug.
-
FDA approval · 2011-01-25FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for RECLAST (zoledronic acid) filed by Sandoz Inc.
-
FDA approval · 2009-05-13FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for pamidronate disodium by Mylan Institutional LLC under an ANDA.
-
FDA approval · 2006-05-19FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for pamidronate disodium, confirming the regulatory approval for the product.